chr16-1349501-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000007390.3(TSR3):c.875G>A(p.Arg292Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R292P) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000007390.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSR3 | NM_001001410.3 | c.875G>A | p.Arg292Gln | missense_variant | 6/6 | ENST00000007390.3 | NP_001001410.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSR3 | ENST00000007390.3 | c.875G>A | p.Arg292Gln | missense_variant | 6/6 | 1 | NM_001001410.3 | ENSP00000007390 | P1 | |
TSR3 | ENST00000566296.1 | c.*245G>A | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 3 | ENSP00000455722 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251212Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135830
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461344Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 726938
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74522
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at